​

Globus Medical (GMED) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

GMED Stock Forecast

Globus Medical (GMED) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $85.00, with a high of $100.00 and a low of $77.00. This represents a -8.01% decline from the last price of $92.40.

$45 $56 $67 $78 $89 $100 High: $100 Avg: $85 Low: $77 Last Closed Price: $92.4

GMED Stock Rating

Globus Medical stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (72.73%), 3 Hold (27.27%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 3 8 Strong Sell Sell Hold Buy Strong Buy

GMED Price Target Upside V Benchmarks

TypeNameUpside
StockGlobus Medical-8.01%
SectorHealthcare Stocks 25.00%
IndustryMedical Device Stocks6.94%

Price Target Trends

1M3M12M
# Anlaysts-17
Avg Price Target-$100.00$76.86
Last Closing Price$92.40$92.40$92.40
Upside/Downside-8.23%-16.82%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 25555--15
Jan, 25555-116
Dec, 24555-116
Nov, 244571118
Oct, 244771120
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2024Kallum TitchmarshMorgan Stanley$100.00$85.5216.93%8.23%
Aug 28, 2024Ryan ZimmermanBTIG$77.00$71.737.35%-16.67%
Aug 07, 2024Vik ChopraWells Fargo$78.00$70.5310.59%-15.58%
Jul 15, 2024Drew RanieriMorgan Stanley$71.00$71.07-0.10%-23.16%
May 29, 2024Ryan ZimmermanBTIG$72.00$65.499.94%-22.08%
May 20, 2024Matt O'BrienPiper Sandler$80.00$64.4024.22%-13.42%
Mar 18, 2024Ryan ZimmermanBTIG$60.00$51.6516.17%-35.06%
Sep 19, 2023Mathew BlackmanStifel Nicolaus$61.00$53.0415.01%-33.98%
Jan 06, 2023Morgan Stanley$78.00$71.988.36%-15.58%
Dec 20, 2022Truist Financial$85.00$71.3619.11%-8.01%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 06, 2024NeedhamHoldHoldhold
Nov 06, 2024Bank of America SecuritiesUnderperformUnderperformhold
Oct 08, 2024RBC CapitalOutperformOutperformhold
Aug 28, 2024BTIGBuyBuyhold
Aug 13, 2024BarclaysOverweightOverweighthold
Jul 15, 2024Morgan StanleyEqual-WeightEqual-Weighthold
May 29, 2024BTIGBuyBuyhold
May 09, 2024BarclaysOverweightOverweighthold
Mar 18, 2024Truist FinancialBuyBuyhold
Mar 18, 2024BTIGBuyupgrade

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.04$1.48$1.89$1.09-----
Avg Forecast$1.36$2.02$2.03$2.31$2.99$3.43$3.93$4.62$4.89
High Forecast$1.34$2.00$2.02$2.28$2.92$3.24$3.13$4.58$4.84
Low Forecast$1.37$2.04$2.04$2.34$3.01$3.56$4.55$4.67$4.94
Surprise %-23.53%-26.73%-6.90%-52.81%-----

Revenue Forecast

$500M $1B $2B $2B $3B $4B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$789.04M$958.10M$1.02B$1.57B-----
Avg Forecast$786.87M$951.95M$1.02B$1.56B$2.51B$2.67B$2.85B$3.06B$3.32B
High Forecast$780.99M$944.84M$1.02B$1.55B$2.50B$2.66B$2.85B$3.05B$3.30B
Low Forecast$791.54M$957.61M$1.03B$1.57B$2.53B$2.69B$2.85B$3.06B$3.35B
Surprise %0.28%0.65%-0.20%0.59%-----

Net Income Forecast

$0 $120M $240M $360M $480M $600M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$102.28M$149.19M$190.17M$122.87M-----
Avg Forecast$46.18M$118.77M$156.07M$122.87M$339.44M$389.74M$466.32M$529.89M$560.54M
High Forecast$17.16M$95.02M$124.85M$98.30M$334.27M$371.02M$358.42M$524.83M$555.10M
Low Forecast$75.19M$142.53M$187.28M$147.45M$344.61M$408.46M$521.58M$534.94M$565.80M
Surprise %121.51%25.61%21.85%------

GMED Forecast FAQ

Is Globus Medical stock a buy?

Globus Medical stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Globus Medical is a favorable investment for most analysts.

What is Globus Medical's price target?

Globus Medical's price target, set by 11 Wall Street analysts, averages $85 over the next 12 months. The price target range spans from $77 at the low end to $100 at the high end, suggesting a potential -8.01% change from the previous closing price of $92.4.

How does Globus Medical stock forecast compare to its benchmarks?

Globus Medical's stock forecast shows a -8.01% downside, underperforming the average forecast for the healthcare stocks sector (25.00%) and underperforming the medical device stocks industry (6.94%).

What is the breakdown of analyst ratings for Globus Medical over the past three months?

  • February 2025: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 31.25% Strong Buy, 31.25% Buy, 31.25% Hold, 0% Sell, 6.25% Strong Sell.
  • December 2024: 31.25% Strong Buy, 31.25% Buy, 31.25% Hold, 0% Sell, 6.25% Strong Sell.

What is Globus Medical’s EPS forecast?

Globus Medical's average annual EPS forecast for its fiscal year ending in December is $2.99 for 2024, a 174.31% increase from the reported $1.09 in 2023. The prediction for 2025 is $3.43, $3.93 for 2026, $4.62 for 2027, and $4.89 for 2028.

What is Globus Medical’s revenue forecast?

Globus Medical's average annual revenue forecast for its fiscal year ending in December is $2.51B for 2024, a 59.81% increase from the reported $1.57B in 2023. The forecast for 2025 is $2.67B, $2.85B for 2026, $3.06B for 2027, and $3.32B for 2028.

What is Globus Medical’s net income forecast?

For its fiscal year ending in December, Globus Medical's average annual net income forecast is $339.44M for 2024, reflecting an 176.26% increase from the reported $122.87M in 2023. The projection for 2025 is $389.74M, $466.32M for 2026, $529.89M for 2027, and $560.54M for 2028.